Showing results (91-100 of 212) with videos related to

Sort By:
Pageof 22
American Journal of Clinical Oncology|March 24, 2012
Phase I trial of AEG35156 an antisense oligonucleotide to XIAP plus gemcitabine in patients with metastatic pancreatic ductal adenocarcinomaDaruka Mahadevan, Pavani Chalasani, Diane Rensvold, et al.
Molecular Cancer Research : MCR|May 4, 2011
High-throughput RNAi screening identifies a role for TNK1 in growth and survival of pancreatic cancer cellsMeredith C Henderson, Irma M Gonzales, Shilpi Arora, et al.
Scientific Reports|October 7, 2023
Advanced glycation end product (AGE) targeting antibody SIWA318H is efficacious in preclinical models for pancreatic cancerGabriela R Rossi, Ashley Jensen, Serina Ng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignanciesDavid W Nyman, Kimberley J Campbell, Evan Hersh, et al.
World Journal of Gastrointestinal Oncology|September 18, 2015
Adenosquamous carcinoma of the pancreas: Molecular characterization of 23 patients along with a literature reviewErkut Borazanci, Sherri Z Millis, Ron Korn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
Validation of TPX2 as a potential therapeutic target in pancreatic cancer cellsSteven L Warner, Bret J Stephens, Stanley Nwokenkwo, et al.
Cancer Chemotherapy and Pharmacology|December 7, 2006
Erlotinib plus gemcitabine in patients with unresectable pancreatic cancer and other solid tumors: phase IB trialTomislav Dragovich, Mark Huberman, Daniel D Von Hoff, et al.
Molecular Cancer Therapeutics|April 14, 2007
Identification of a novel inhibitor of urokinase-type plasminogen activatorMing Zhu, Vijay M Gokhale, Lajos Szabo, et al.
Molecular Cancer Therapeutics|January 14, 2009
UA62784, a novel inhibitor of centromere protein E kinesin-like proteinMeredith C Henderson, Yeng-Jeng Y Shaw, Hong Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2019
NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivorsAndrea Wang-Gillam, Richard A Hubner, Jens T Siveke, et al.
Pageof 22